Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00014690
Status:
COMPLETED
Last Update Posted:
2013-08-02
First Post:
2001-04-10
Brief Title:
ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer Fallopian Tube Cancer or Primary Peritoneal Cancer
Sponsor:
AstraZeneca
Organization:
National Cancer Institute NCI